orphan annie, analytica and the autostart, page-8

I don't understand what this ding's problem is and what he/she is getting at by comparing MLA's bottom line to ALT.

MLA is going to be manufacturing marketing and distributing the Analytica product (Autostart Burette). It is Analytica's IP, but MLA is going to be taking it to market (and presumably will be making the bul of the margin, given its role/s).

MLA has multiple global manufacturing facilities as well as global marketing and distribution channels. It obviously has costs and has had cash burn, but if you look at the contracts in place and the markets it is developing, together with announcements of predicted sales, the burn is quickly burning away and the company is looking at a nice and profitable 2012.

Ding, comparing the two companies is like comparing apples with bananas. ALT needs MLA in order to be successful, otherwise it will keep relying on loans from its Directors and will be forced into another Cap Raise like the $2m+ it just needed to raise last month in order to stay afloat...

...the orginal message from another poster here was that ALT holders should be looking at MLA as an investment opportunity...